Rad Chat

Naman Julka-Anderson and Jo McNamara catch up with Dr. John Christodouleas about his career, medical affairs and MR Linac based research.
 
To use this podcast as CPD, look at these reflection points: 
1) reflect on your motivations for working in healthcare.
2) consider the differences in private and public healthcare.
3) consider ways to improve access to radiotherapy.

Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:
MR-Linac Consortium Website: https://mrlconsortium.org
Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac: https://www.redjournal.org/article/S0360-3016(23)06346-0/fulltext
Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05415-9/fulltext
Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05720-6/fulltext
Optimising the MR-Linac as a standard treatment modality: https://onlinelibrary.wiley.com/doi/10.1002/jmrs.712
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy: https://www.redjournal.org/article/S0360-3016(23)07949-X/fulltext
Development of prostate bed delineation consensus guidelines for MRI-guided radiotherapy and assessment of its impact on interobserver variability: https://www.redjournal.org/article/S0360-3016(23)07848-3/fulltext
Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors: Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors - Radiotherapy and Oncology(thegreenjournal.com)

Please like and subscribe to Rad Chat on your podcast library.

Our links:
Link Tree:https://linktr.ee/radchat 
Facebook:https://www.facebook.com/RadChatPodcast/ 
Instagram:https://www.instagram.com/rad__chat/ 
LinkedIn:https://uk.linkedin.com/company/radtalk 
Tik Tok:https://www.tiktok.com/@rad_chat 
Twitter:https://twitter.com/rad__chat?lang=en 
YouTube: https://www.youtube.com/@radchat2259

Music and jingle credits: Dr. Ben Potts and Adam Cooke.

© Rad Chat 2025. All rights reserved.  
We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  
You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  
You must not use any images, audio, video, graphics or clips separately from their accompanying context.  
Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

What is Rad Chat?

Rad Chat is a forward-thinking global knowledge hub where healthcare professionals can advance their knowledge and expertise in radiotherapy and oncology by utilising the award winning, first therapeutic radiographer led oncology podcast and social media channels.

We're empowering healthcare professionals worldwide by providing free, CPD-accredited radiotherapy and oncology education, by sharing real-world experience, expert insights, best practice and patient perspectives, we're helping healthcare professionals’ advance cancer care and improve patient outcomes.